VertiFlex has raised $26.8 million in funding, according to an Orange County Business Journal report.
Here are three points:
1. VertiFlex proposes to raise a total of $45.7 million in funding.
2. The company's Superion Interspinous Spacer device received pre-market approval from the FDA last year to treat moderate lumber spinal stenosis.
3. VertiFlex has raised $93 million in funding rounds since 2007.